iFAST (SGX:AIY) Is Up 5.2% After Strong Q3 Earnings and Net Income Growth – What's Changed
iFAST Corporation Ltd. reported strong Q3 earnings with significant year-over-year increases in sales, revenue, and net income, leading to a 5.2% stock price rise. The company aims for SGD716.4 million in revenue and SGD163.0 million in earnings by 2028, requiring 18.5% annual growth. Key risks include execution challenges in new markets, particularly in China and the U.K. The ramp-up of Hong Kong’s ePension business is crucial for future profitability. Analysts estimate iFAST's fair value between S$7.30 and S$12.56, indicating potential upside or downside from current prices.
- iFAST Corporation Ltd. reported its financial results for the third quarter and nine months ended September 30, 2025, posting strong year-over-year increases in sales, revenue, and net income.
- This robust performance also translated into higher basic and diluted earnings per share across both quarterly and year-to-date periods, highlighting ongoing operational momentum.
- We'll explore how the sustained growth in net income and revenue strengthens iFAST's long-term investment narrative and growth prospects.
We've found 21 US stocks that are forecast to pay a dividend yield of over 6% next year. See the full list for free.
iFAST Investment Narrative Recap
To be a shareholder in iFAST, one must believe in its capability to sustain rapid earnings and revenue growth while successfully scaling new business lines such as ePension and digital banking. The robust third quarter results reinforce management’s operational momentum, yet execution risk in new markets, especially the continued losses in China and the early stage of U.K. operations, remains the key short-term catalyst and the biggest risk. These recent results do not fundamentally shift the balance of these risks and catalysts.
Among recent announcements, the ramp-up of Hong Kong’s ePension business stands out as the most relevant development. This initiative is closely linked to iFAST’s recurring revenue ambitions and operational leverage, as onboarding moves toward completion. Efficient execution here could support ongoing profit and margin improvements, but the risk lies in managing rising expenses without delay.
However, it’s important to remember that not all drivers of growth are within management control, particularly if...
Read the full narrative on iFAST (it's free!)
iFAST's narrative projects SGD716.4 million revenue and SGD163.0 million earnings by 2028. This requires 18.5% yearly revenue growth and an earnings increase of SGD85.8 million from current earnings of SGD77.2 million.
Uncover how iFAST's forecasts yield a SGD10.89 fair value, a 12% upside to its current price.
Exploring Other Perspectives
Five members of the Simply Wall St Community estimate iFAST's fair value between S$7.30 and S$12.56. With revenue and net income surging, much will depend on how effectively iFAST converts onboarding progress in Hong Kong into meaningful long-term margin gains.
Explore 5 other fair value estimates on iFAST - why the stock might be worth 25% less than the current price!
Build Your Own iFAST Narrative
Disagree with existing narratives? Create your own in under 3 minutes - extraordinary investment returns rarely come from following the herd.
- A great starting point for your iFAST research is our analysis highlighting 3 key rewards and 1 important warning sign that could impact your investment decision.
- Our free iFAST research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate iFAST's overall financial health at a glance.
Curious About Other Options?
Markets shift fast. These stocks won't stay hidden for long. Get the list while it matters:
- Rare earth metals are an input to most high-tech devices, military and defence systems and electric vehicles. The global race is on to secure supply of these critical minerals. Beat the pack to uncover the 36 best rare earth metal stocks of the very few that mine this essential strategic resource.
- AI is about to change healthcare. These 34 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
- Uncover the next big thing with financially sound penny stocks that balance risk and reward.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
